This document discusses two case studies of patients presenting with polyposis and other features. The first case is a 45-year-old man who previously had colon polyps and jejunal adenocarcinoma. Genetic testing was negative for familial adenomatous polyposis (FAP). The second case details a family with a history of colon cancer and a brain tumor. Genetic testing found the patient has a constitutional mismatch repair deficiency (CMMRD), also known as Turcot syndrome, caused by biallelic mutations in the PMS2 gene. CMMRD is characterized by colon polyps and brain tumors occurring at a young age. The document provides background on Turcot syndrome and compares the features
Companion slideshow for polyppolyp.com (Familial adenomatous polyposis)Douglas Riegert-Johnson
A companion slideshow to the polypolyp.com website. The website is designed to assist in polyposis care, education and documentation. (c) 2014 Douglas Riegert-Johnson.
Companion slideshow for polyppolyp.com (Familial adenomatous polyposis)Douglas Riegert-Johnson
A companion slideshow to the polypolyp.com website. The website is designed to assist in polyposis care, education and documentation. (c) 2014 Douglas Riegert-Johnson.
Family First: What you need to know about family history, genetic testing, a...Fight Colorectal Cancer
Have you and your family talked about the importance of knowing your family's medical history?
Did you know that 3% of all colorectal cancers are due to a syndrome called Lynch syndrome? Having Lynch syndrome puts you at an 80% increased risk of developing colorectal cancer.
This webinar will focus more about Lynch Syndrome and other inherited syndromes as they relate to colorectal cancer.
Heather Hampel, a genetics counselor from Ohio State University will discuss the importance of knowing your family history. She'll talk about when, how and where to find a genetics counselor, and what is it you should discuss with them.
HEAD AND NECK OCCULT PRIMARY CANCERS. SAM & RICH.pptxRitchieShija
Carcinoma of unknown primary is a diagnosis given when doctors aren't able to locate where a cancer began.
Most often, cancer is diagnosed when doctors discover the spot where the cancer began (primary tumor). If the cancer has spread (metastasized), those sites might be discovered, too.
In carcinoma of unknown primary, also known as occult primary cancer, doctors find the cancer cells that spread in the body, but they can't find the primary tumor.
In carcinoma of unknown primary, also known as occult primary cancer, doctors find the cancer cells that spread in the body, but they can't find the primary tumor. Doctors consider the location of the primary tumor when choosing the most appropriate treatments.So if carcinoma of unknown primary is found, doctors work to try to identify the primary tumor site. Your doctor might consider your risk factors, symptoms, and results from exams, imaging tests and pathology tests when trying to determine where your cancer began.
6. To Strut and Fret Salivary Glands: New Entities, Old EnemiesSingapore sali...nahu9
Salivary Gland Tumors
• One of the most difficult areas of ENT pathology
• Rare – few pathologists see high volumes
• Tremendous variety
• Even a single tumor type (e.g., pleomorphic adenoma) may show
marked morphologic variability
• Difficult to stay up-to-date on new findings altering classification
EXPRESSION OF CK5 BASAL CYTOKERATIN DURING METASTATIC DEVELOPMENT OF BREAST C...ANCA MARIA CIMPEAN
Objective. Breast cancer is a one of the most common cancers in females worldwide. Basal cytokeratin CK5 represent the marker of progenitors for glandular and myoepithelial lineages of mammary epithelium. During epithelial differentiation there is a gradual decrease of CK5 expression. The purpose of this study was to compare the expression of basal cytokeratin CK5 vs hormone receptors, HER2, Ki67 and molecular subtypes immunohistochemically defined in the primary breast carcinoma of NST type and axillar lymph node metastasis. Material and Methods. We processed immunohistochemically 91 invasive breast carcinomas of NST type and their ipsilateral axillar lymph node metastasis (LNM). Results. The majority of primary tumors were evaluated as CK5 negative (78 cases/85.7%). The majority of cases were evaluated as Luminal B (50 cases/54.9%) and Luminal A (28 cases/30.8%) tumors. The HER2 subtype was confirmed in 8 cases/8.8%, 5NP in 3 cases/3.3% and Basal-like in 2 cases/2.2%. The parallel comparison of CK5 expression at both sites, primary and metastatic, revealed that this marker is not stable during metastatic progression. The molecular subtypes were not stable during metastatic process in 21 cases/23.1%. Conclusions. The majority of NST invasive ductal breast carcinomas are CK5 negative. The molecular subtypes and CK5 are not stable during metastatic process. Cancerous cells prefer to lose this marker in the lymph node environment. The presence of cases with simultaneous expression of CK5 and hormone receptors is an open field to debate the existence of other, transient molecular subtypes. We expect a further confirmation in larger study groups.
Key Words: molecular subtypes, invasive carcinoma NST type, basal cytokeratin.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
3. CASE1
A 45 year-old man presented for medical genetics
evaluation. Between the ages of 20 and 30
years, the patient had nasal polyps and several
large stalked colon polyps removed. At 43
years-old, he was diagnosed with jejunal
adenocarcinoma (T1N0). Upper endoscopy
following surgery showed several stomach and
small bowel polyps. A genetic test for familial
adenomatosis polyposis (APC gene) was
negative. There was no family history of
cancer.
What is the diagnosis?
4.
5. NASAL POLYPOSIS
Originally published in Dutch as: Peutz J. Very remarkable
case of familial polyposis of mucous membrane of
intestinal tract and nasopharynx accompanied by
peculiar pigmentations of skin and mucous membrane.
Nederl Maandschr Geneesk. 1921; 10:134-146.
7. CASE2
4 years old. Alive and well.
28 years old
Alive and well
48 years old
Thyroid disease
50 years old
Alive and well
25 yo dx with transverse
CRC,
25 tubular adenomas in left
colon (right colon not seen
due to obstruction).
A few stomach polyps.
At 22 yo dx left temporal
lobe glioblastoma.
“Freckles in Eye”.
8.
9. CASE2
4 years old. Alive and well.
28 years old
Alive and well
48 years old
Thyroid disease
50 years old
Alive and well
25 yo dx with transverse
CRC,
25 tubular adenomas in left
colon (right colon not seen
due to obstruction)
A few stomach polyps.
At 22 yo dx left temporal
lobe glioblastoma.
“Freckles in Eye”.
DX: ? FAP NEW
MUTATION TURCOT
10. TERM “TURCOT SYNDROME”
AS CURRENTLY USED
FAP + brain tumor (usually meduloblastoma) = Turcot
syndrome
LS + brain tumor (usually glioblastoma) = Turcot
syndrome
11. TURCOT SYNDROME
Described in 1959 by Jacques Turcot in Diseases of the Colon and
Rectum
Hôtel Dieu de Quebec hospital (1640) and the Laval University
2 teenage siblings with numerous colorectal polyps. The brother (15
years old) with meduloblastoma of the spinal cord and
adenocarcinomas of the sigmoid colon and rectum. The sister (13
years old) with cerebral glioblastoma and pituitary adenoma.
Mckusick and Osler communicated that parents were third cousins.
Crail Syndrome case report (1949)
Adenomatous polyposis, mebullastoma of the brain stem, and
papillary thyroid cancer.
New England Journal Medicine article describing molecular phenotype.
Turcot original report 1959. 13839882.
12. CASE2
4 years old. Alive and well.
28 years old
Alive and well
48 years old
Thyroid disease
50 years old
Alive and well
25 yo dx with transverse
CRC,
25 tubular adenomas in left
colon (right colon not seen
due to obstruction)
A few stomach polyps.
At 22 yo dx left temporal
lobe glioblastoma.
“Freckles in Eye”.
Test Diagnosis Result
APC
MUTYH
MLH1/MSH2
Mismatch repair gene IHC
DNA Microsatellite Instability
DX: ? FAP NEW
MUTATION TURCOT
13. CASE2
4 years old. Alive and well.
28 years old
Alive and well
48 years old
Thyroid disease
50 years old
Alive and well
25 yo dx with transverse
CRC,
25 tubular adenomas in left
colon (right colon not seen
due to obstruction)
A few stomach polyps.
At 22 yo dx left temporal
lobe glioblastoma.
“Freckles in Eye”.
Test Diagnosis Result
APC FAP
MUTYH MAP
MLH1/MSH2 Lynch syndrome 2 genes
Mismatch repair gene IHC Lynch syndrome 5 genes
DNA Microsatellite Instability Lynch syndrome 5 genes
DX: ? FAP NEW
MUTATION TURCOT
14. CASE2
4 years old. Alive and well.
28 years old
Alive and well
48 years old
Thyroid disease
50 years old
Alive and well
25 yo dx with transverse
CRC,
25 tubular adenomas in left
colon (right colon not seen
due to obstruction)
A few stomach polyps.
At 22 yo dx left temporal
lobe glioblastoma.
“Freckles in Eye”.
Test Diagnosis Result
APC FAP Normal
MUTYH MAP Normal
MLH1/MSH2 Lynch syndrome 2
genes
Normal
Mismatch repair gene IHC Lynch syndrome 5 Abnormal
DX: ? FAP NEW
MUTATION TURCOT
15. Normal Staining of PMS2 in tumor.
Both copies of PMS2 present.
Lynch syndrome. No staining in
tumor. (Both copies of PMS2
inactivated, one inherited, one
acquired in tumor) Staining in tumor
lymphocytes and normal tissue.
Patient Results: Constitutional mismatch repair deficiency.
No staining in tumor and normal tissue.
(Both copies of PMS2 inactivated in tumor and normal by inherited mutations.)
16. CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY
First described in 1999 in two simultaneously published
reports (Ricciardone et al. 1999; Wang et al. 1999)
Synonyms.
Childhood cancer syndrome (CCS)
Lynch III syndrome
„„CoLoN‟‟, Colon tumours or/and Leukaemia/Lymphoma
Constitutional mismatch repair-deficiency syndrome:
have we so far seen only the tip of an iceberg?
17. MICRO SATELLITE INSTABILITY UNRELIABLE IN
CMMRD
DNA measurements of microsatellite instability based
on comparing normal and tumor tissue MS. In LS,
the tumor MS change, so a difference can be seen.
(I think) in CMMRD normal and tumor both change
so no difference can be seen.
Only one out of the 14 brain tumours exhibited an
MSI-high genotype.
Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: Report from the constitutional
mismatch repair deficiency consortium. 24440087.
18. CMMR OVERLAPS WITH NF1: CASE 2 WITH 50 CALM.
All CMMRD patients with available clinical data (n = 18) had café-
au-lait spots (>6 spots) and three patients had
hypopigmentation. Three individuals had axillary freckles, and
one had a plexiform neurofibroma; meeting the criteria for NF-1,
but lacked germline NF-1 mutations.
Genetic and clinical determinants of constitutional mismatch repair deficiency
syndrome: Report from the constitutional mismatch repair deficiency consortium.
. 24440087.
19. TUMOR SPECTRUM OF CMMRD IN 92 PATIENTS
Cancer Number Median age (range)
of diagnosis
Hematological 30 6 (0.4-17)
Brain tumor 44 8 (2-35)
Colorectal cancer 37 16 (8-35)
Small bowel 9 26 (11-42)
2010 CMMRD Review of 92 patients.
20. DIFFERENCES IN TUMOR SPECTRUM BASED ON
GENOTYPE IN CMMRD
PMS2/MSH6> MLH1/MSH2
n 65 24
Median age of dx 9 years 4 years
Hematological
(#1 Non Hodgkins Lymphoma
Tcell)
29%
46%
Brain
35% 8%
Lynch syndrome cancer
(colon, endometrial)
68% 29%
21. CMMRD MUTATION SPECTRUM
PMS2 dominates, followed by MSH6 and MLH1.
“MSH2 mutations which are most commonly found in
Lynch syndrome are less common to absent in
CMMRD, while PMS2 and MSH6 are more commonly
observed in the syndrome. A possible explanation for
this phenomenon is low penetrance of heterozygous
mutations in MSH6 and PMS2 found in CMMRD and the
deleterious functional consequence of homozygous
mutations. Highly penetrant mutations in MSH2, may
be embryonically lethal when homozygous leading to
the lower prevalence observed in CMMRD.”
22. LABORATORY FINDINGS OF CMMRD: IGG CLASS
SWITCH
Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination. 18824584.
23. Surveillance protocol for patient with for Biallelic MMR mutations.
Cancer Surveillance strategy
Children
Colon Colonoscopy annuallya
Upper GI tract and small
bowel
EGD annuallya,
video capsule endoscopy annuallya
Brainb Ultrasound at birth then MRI brain every 6 months
Leukemiab, Lymphomab Complete blood count, erythrocyte sedimentation rate,
lactate dehydrogenase every 4 months
Adults
Colon Colonoscopy annuallya
Upper GI tract and small
bowel
EGD annuallya,
video capsule endoscopy annuallya
Brainb Ultrasound at birth then MRI brain every 6 months
Leukemiab, Lymphomab Complete blood count, erythrocyte sedimentation rate,
lactate dehydrogenase every 4 months
Uterus Ultrasound annually
Upper urinary tract Ultrasound and urine cytology annually
EGD-esophagogastroduodenoscopy. a To start at 3 years of age or at diagnosis; b Brain,
leukemia/lymphoma screening should commence at birth if diagnosed prenatally.
Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: Report from the constitutional
mismatch repair deficiency consortium. 24440087.
24. EU CMMRD PARIS - JUNE 2013
“In 1968, criteria were proposed by WHO
that should be met prior to the
implementation of screening
programmes. These criteria were used to
assess surveillance in CMMR-D. The
evaluation showed that surveillance for
CRC is the only part of the programme
that largely complies with the WHO
criteria.”
Guidelines for surveillance of individuals with constitutional mismatch
repair-deficiency proposed by the European Consortium "Care for CMMR-
D" (C4CMMR-D). J Med Genet. Vasen HF and others behalf of the EU-
Consortium Care for CMMR-D (C4CMMR-D).
25.
26. CASE 2 GENETIC TEST RESULTS
4 years old. Alive and well.
28 years old
Alive and well
48 years old
Thyroid disease
50 years old
Alive and well
PMS2 gene
mutation
(Pro246Cysfsx3)
PMS2 gene
mutation
(Ile611Asnfsx3)
25 yo dx
with
transverse
CRC.
PMS2 gene
wildtype
(normal)
CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY =
1 LS MUTATION FROM FATHER, AND 1 FROM MOTHER,
(BIALLELIC)
27. CASE 2 GENETIC TEST RESULTS
4 years old. Alive and well.
28 years old
Alive and well
48 years old
Thyroid disease
50 years old
Alive and well
PMS2 gene
mutation
(Pro246Cysfsx3)
PMS2 gene
mutation
(Ile611Asnfsx3)
PMS2 gene
wildtype
(normal)
25 yo dx
with
transverse
CRC.
or
28. ECCLESIASTES 1:9
The thing that hath been, it is that which
shall be; and that which is done is that
which shall be done: and there is no new
thing under the sun.
29. Described in 1959 by Jacques Turcot in Diseases of the Colon and
Rectum
Hôtel Dieu de Quebec hospital (1640) and the Laval University
2 teenage siblings with numerous colorectal polyps. The brother
(15 years old) with meduloblastoma of the spinal cord and
adenocarcinomas of the sigmoid colon and rectum. The sister (13
years old) with cerebral glioblastoma and pituitary adenoma.
Mckusick and Osler communicated that parents were third
cousins.
“Every case of familial polyposis should be followed
and explored, not only looking for new occurrences
of polyps in the colon and rectum, when they are not
removed by also for the appearance of other tissue
tumors elsewhere in the body.”
30.
31. FEATURES OF TURCOT BY ITOH AND OTHERS
(1) In Turcot's syndrome the manifestations of brain tumour and colonic
polyposis are significantly associated and are not merely coincidental,
although the association of brain tumour is only incidental in the few cases of
familial polyposis coli.
(2) Moreover, an autosomal recessive mode of transmission is most likely in this
syndrome.
(3) The number of colonic polyps in Turcot's syndrome was frequently less than
100, in contrast with the study of Bussey (1975) who noted that the average
number of polyps in familial polyposis coli was about 1000 and rarely less
than 200. The analysis of macroscopic findings of colonic polyps showed that
they were fewer in number and larger in size in Turcot's syndrome compared
with familial polyposis coli.
(4) Therefore, we present the hypothesis that Turcot's syndrome is
genetically distinct from familial polyposis coli.
Turcot syndrome and its characteristic colonic
manifestations.
Itoh H, Ohsato K. Dis Colon Rectum. 1985 Jun;28(6):399-
32. There were several cafr-au-lait spots on the
skin of the chest, back, abdomen, and extremities,
but there were no nodules on the body surface.
H Itoh and others, Gut
1979. Kyushu University
Faculty of Medicine,
Fukuoka, Japan.
“There were several
cafe-au-lait spots on
the
skin of the chest,
back, abdomen, and
extremities, but
there were no
nodules on the body
surface.”
33. Proband. 13 yo from
Brazil. Youngest in a
family of 7 children. No
gastric or extracolonic
features of FAP.
34.
35.
36. Compared with familial polyposis coli, colonic polyps in Turcot‟s syndrome are fewer in
number and larger in size.
Editor's Notes
Agenesis of the corpus callosum and gray matter heterotopia in three patients with constitutional mismatch repair deficiency syndromeAnnette F Baas